Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6043441 | World Neurosurgery | 2016 | 24 Pages |
Abstract
SRS with a dose of 25 Gy in 5 sessions is associated with excellent local control at the resection site with minimal toxicity in the postoperative settings in our patient population. Further investigation is required to determine if dose escalation to the postoperative cavity of radioresistant tumors improves outcomes.
Keywords
RadioresistantGTVPTVWBRTLMDSRSMRIPlanning target volumeoverall survivalLeptomeningeal diseaseMagnetic resonance imaginggross tumor volumeSRS, Stereotactic radiosurgeryNSCLCconfidence intervalBrain metastaseshazard ratioWhole-brain radiation therapyNon–small cell lung carcinomaKaplan-MeierLocal control
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Yazan Abuodeh, Kamran A. Ahmed, Arash O. Naghavi, Puja S. Venkat, Siriporn Sarangkasiri, Peter A.S. Johnstone, Arnold B. Etame, Hsiang-Hsuan Michael Yu,